142 related articles for article (PubMed ID: 9417494)
1. [Selenium administration in patients with sepsis syndrome. A prospective randomized study].
Zimmermann T; Albrecht S; Kühne H; Vogelsang U; Grützmann R; Kopprasch S
Med Klin (Munich); 1997 Sep; 92 Suppl 3():3-4. PubMed ID: 9417494
[TBL] [Abstract][Full Text] [Related]
2. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.
Angstwurm MW; Engelmann L; Zimmermann T; Lehmann C; Spes CH; Abel P; Strauss R; Meier-Hellmann A; Insel R; Radke J; Schüttler J; Gärtner R
Crit Care Med; 2007 Jan; 35(1):118-26. PubMed ID: 17095947
[TBL] [Abstract][Full Text] [Related]
3. [Selenium administration in sepsis patients].
Gärtner R; Angstwurm MW; Schottdorf J
Med Klin (Munich); 1997 Sep; 92 Suppl 3():12-4. PubMed ID: 9417486
[TBL] [Abstract][Full Text] [Related]
4. SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX-trial): study design of an international multicenter randomized double-blinded controlled trial of high dose sodium-selenite administration in high-risk cardiac surgical patients.
Stoppe C; McDonald B; Rex S; Manzanares W; Whitlock R; Fremes S; Fowler R; Lamarche Y; Meybohm P; Haberthür C; Rossaint R; Goetzenich A; Elke G; Day A; Heyland DK
Trials; 2014 Aug; 15():339. PubMed ID: 25169040
[TBL] [Abstract][Full Text] [Related]
5. [Pharmaconutrition with parenteral selenium in sepsis].
Langlois PL; de Oliveira Figliolino LF; Hardy G; Manzanares W
Med Intensiva; 2014 Apr; 38(3):173-80. PubMed ID: 24021703
[TBL] [Abstract][Full Text] [Related]
6. Pharmaconutrition with selenium in critically ill patients: what do we know?
Manzanares W; Langlois PL; Heyland DK
Nutr Clin Pract; 2015 Feb; 30(1):34-43. PubMed ID: 25524883
[TBL] [Abstract][Full Text] [Related]
7. [Significance of selenium in intensive care medicine. Clinical studies of patients with SIRS/sepsis syndrome].
Gärtner R; Angstwurm M
Med Klin (Munich); 1999 Oct; 94 Suppl 3():54-7. PubMed ID: 10554531
[TBL] [Abstract][Full Text] [Related]
8. [Effect of selenium administration on various laboratory parameters of patients at risk for sepsis syndrome].
Lehmann C; Egerer K; Weber M; Krausch D; Wauer H; Newie T; Kox WJ
Med Klin (Munich); 1997 Sep; 92 Suppl 3():14-6. PubMed ID: 9417487
[TBL] [Abstract][Full Text] [Related]
9. [Clinical data on the use of selenase in sepsis].
Lehmann Ch
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S411-3. PubMed ID: 19998233
[No Abstract] [Full Text] [Related]
10. Selenium in intensive care (SIC) study: the XX files are still unresolved.
Schomburg L
Crit Care Med; 2007 Mar; 35(3):995-6; author reply 996-7. PubMed ID: 17421119
[No Abstract] [Full Text] [Related]
11. [Significance of selenium in regulation of inflammatory response by transcription factors in polytrauma patients. A clinical study].
von Gagern G; Zimmermann T; Albrecht S; Bachmann L; Zwipp H; Saeger HD
Med Klin (Munich); 1999 Oct; 94 Suppl 3():62-5. PubMed ID: 10554533
[TBL] [Abstract][Full Text] [Related]
12. [Pentoxifylline as adjuvant therapy of multiple organ failure].
Schröder J; Staubach KH; Stüber F; Zabel P
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):461-5. PubMed ID: 14518297
[TBL] [Abstract][Full Text] [Related]
13. Selenium supplementation in the critically ill: posology and pharmacokinetics.
Manzanares W; Hardy G
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):273-80. PubMed ID: 19333120
[TBL] [Abstract][Full Text] [Related]
14. [Mediator modulation in infection and multiple organ failure].
Majetschak M; Obertacke U; Waydhas C; Nast-Kolb D; Schade FU
Unfallchirurg; 2000 Oct; 103(10):903-7. PubMed ID: 11098752
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure.
Abraham E; Naum C; Bandi V; Gervich D; Lowry SF; Wunderink R; Schein RM; Macias W; Skerjanec S; Dmitrienko A; Farid N; Forgue ST; Jiang F
Crit Care Med; 2003 Mar; 31(3):718-28. PubMed ID: 12626975
[TBL] [Abstract][Full Text] [Related]
16. High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study.
Manzanares W; Biestro A; Galusso F; Torre MH; Mañáy N; Facchin G; Hardy G
Nutrition; 2010 Jun; 26(6):634-40. PubMed ID: 20080034
[TBL] [Abstract][Full Text] [Related]
17. [Progress in therapy of infection].
Müller-Werdan U; Buerke M; Werdan K
Internist (Berl); 2003 Dec; 44(12):1531-40. PubMed ID: 14689196
[No Abstract] [Full Text] [Related]
18. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.
Poeze M; Froon AH; Ramsay G; Buurman WA; Greve JW
Shock; 2000 Oct; 14(4):421-8. PubMed ID: 11049104
[TBL] [Abstract][Full Text] [Related]
19. [Is modification of systemic inflammatory response syndrome and multiple organ failure by parenteral feeding possible?].
Bastian L; Weimann A; Regel G; Tscherne H
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1083-5. PubMed ID: 9931797
[TBL] [Abstract][Full Text] [Related]
20. [Anti-inflammatory therapy in sepsis].
Hoffmann JN; Inthorn D; Jauch KW
Chirurg; 2003 Jun; 74(6):587-8; author reply 588-90. PubMed ID: 12883811
[No Abstract] [Full Text] [Related]
[Next] [New Search]
